FDA Launches the Global Reliance Disclosure Program to Expand Patient Access to Medicines Worldwide

FDA today announced the Global Reliance Disclosure Program (GRDP), a landmark initiative that will fundamentally transform how the FDA's regulatory drug and biologic approval decisions are leveraged by health authorities around the world.
Kaynak: FDA Press Releases


